RxDoctor Payments Data

Manjoo Sharma

Internal Medicine · Hempstead, NYNPI 1003857251

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Edwards Lifesciences at 25.6% of the total. Reporting peaked in 2023 at $1,749 and has fallen 52.6% since, to $828 in 2025.

$3,861in general payments, 2019–2025

Across 32 payments — averaging $120.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$989
  • Amgen$849
  • Eli Lilly$760
  • Janssen Research & Development, LLC$620
  • Novartis$519
  • Astellas Pharma US Inc$40
  • plus $84 from 4 others
$5,626,028in research payments, 2019–2025

Across 591 payments — averaging $9519.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Braintree Laboratories, Inc.$1.5M
  • Modernatx, Inc.$936K
  • Merck$711K
  • Eli Lilly$460K
  • AstraZeneca$440K
  • Novartis$410K
  • plus $1.2M from 9 others

What the payments were for

  • Travel & lodging$2,12255%
  • Food & beverage$1,73945%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,861 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Other internal medicine in Hempstead

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →